Perirenal Fat Thickness is Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes Mellitus

References

• Eslam M, Alkhouri N, Vajro P, et al. Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement. Lancet Gastroenterol Hepatol. 2021;6(10):864–873.
   PubMed Web of Science ®Google Scholar
• Targher G, Corey K, Byrne C, et al. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021;18(9):599–612. doi:10.1038/s41575-021-00448-y
   PubMed Web of Science ®Google Scholar
• Younossi Z, Golabi P, de Avila L, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019;71(4):793–801. doi:10.1016/j.jhep.2019.06.021
   PubMed Web of Science ®Google Scholar
• Mantovani A, Scorletti E, Mosca A, et al. Complications, morbidity and mortality of nonalcoholic fatty liver disease. Metab Clin Exp. 2020;111:154170. doi:10.1016/j.metabol.2020.154170
   Web of Science ®Google Scholar
• Agbim U, Carr R, Pickett-Blakely O, et al. Ethnic disparities in adiposity: focus on non-alcoholic fatty liver disease, visceral, and generalized obesity. Curr Obes Rep. 2019;8(3):243–254. doi:10.1007/s13679-019-00349-x
   PubMed Web of Science ®Google Scholar
• Chau Y, Bandiera R, Serrels A, et al. Visceral and subcutaneous fat have different origins and evidence supports a mesothelial source. Nat Cell Biol. 2014;16(4):367–375. doi:10.1038/ncb2922
   PubMed Web of Science ®Google Scholar
• Foster M, Pagliassotti M. Metabolic alterations following visceral fat removal and expansion: beyond anatomic location. Adipocyte. 2012;1(4):192–199. doi:10.4161/adip.21756
   PubMedGoogle Scholar
• D’Marco L, Salazar J, Cortez M, et al. Perirenal fat thickness is associated with metabolic risk factors in patients with chronic kidney disease. Kidney Res Clin Pract. 2019;38(3):365–372. doi:10.23876/j.krcp.18.0155
   PubMed Web of Science ®Google Scholar
• Roever L, Resende E, Veloso F, et al. Perirenal fat and association with metabolic risk factors: the Uberlândia heart study. Medicine. 2015;94(38):e1105. doi:10.1097/MD.0000000000001105
   PubMed Web of Science ®Google Scholar
• Hernández-Conde M, Llop E, Carrillo C, et al. Estimation of visceral fat is useful for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease. World J Gastroenterol. 2020;26(42):6658–6668. doi:10.3748/wjg.v26.i42.6658
   PubMed Web of Science ®Google Scholar
• Eslam M, Newsome P, Sarin S, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202–209. doi:10.1016/j.jhep.2020.03.039
   PubMed Web of Science ®Google Scholar
• DiPietro L, Al-Ansari S, Biddle S, et al. Advancing the global physical activity agenda: recommendations for future research by the 2020 WHO physical activity and sedentary behavior guidelines development group. Int J Behav Nutr Phys Act. 2020;17(1):143. doi:10.1186/s12966-020-01042-2
   PubMed Web of Science ®Google Scholar
• Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23(1):57–63. doi:10.2337/diacare.23.1.57
   PubMed Web of Science ®Google Scholar
• Bril F, McPhaul M, Caulfield M, et al. Performance of plasma biomarkers and diagnostic panels for nonalcoholic steatohepatitis and advanced fibrosis in patients with type 2 diabetes. Diabetes Care. 2020;43(2):290–297. doi:10.2337/dc19-1071
   PubMed Web of Science ®Google Scholar
• Favre G, Grangeon-Chapon C, Raffaelli C, et al. Perirenal fat thickness measured with computed tomography is a reliable estimate of perirenal fat mass. PLoS One. 2017;12(4):e0175561. doi:10.1371/journal.pone.0175561
   PubMed Web of Science ®Google Scholar
• Starekova J, Hernando D, Pickhardt P, et al. Quantification of liver fat content with CT and MRI: state of the art. Radiology. 2021;301(2):250–262. doi:10.1148/radiol.2021204288
   PubMed Web of Science ®Google Scholar
• Zeng MD, Fan JG, Lu LG, et al. Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases. J Dig Dis. 2008;9(2):108–112. doi:10.1111/j.1751-2980.2008.00331.x
   PubMed Web of Science ®Google Scholar
• Lim S, Kim J, Targher G. Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease. Trends Endocrinol Metab. 2021;32(7):500–514. doi:10.1016/j.tem.2021.04.008
   PubMed Web of Science ®Google Scholar
• De Pergola G, Campobasso N, Nardecchia A, et al. Para- and perirenal ultrasonographic fat thickness is associated with 24-hours mean diastolic blood pressure levels in overweight and obese subjects. BMC Cardiovasc Disord. 2015;15:108. doi:10.1186/s12872-015-0101-6
   PubMed Web of Science ®Google Scholar
• Yang Y, Ma Y, Cheng Y, et al. The perirenal fat thickness was independently associated with serum uric acid level in patients with type 2 diabetes mellitus. BMC Endocr Disord. 2022;22(1):210. doi:10.1186/s12902-022-01081-9
   PubMed Web of Science ®Google Scholar
• Lamacchia O, Nicastro V, Camarchio D, et al. Para- and perirenal fat thickness is an independent predictor of chronic kidney disease, increased renal resistance index and hyperuricaemia in type-2 diabetic patients. Nephrol Dial Transplant. 2011;26(3):892–898. doi:10.1093/ndt/gfq522
   PubMed Web of Science ®Google Scholar
• Ke J, Wang Y, Liu S, et al. Relationship of para and perirenal fat and high-density lipoprotein and its function in patients with type 2 diabetes mellitus. Int J Endocrinol. 2021;2021:9286492. doi:10.1155/2021/9286492
   PubMed Web of Science ®Google Scholar
• Manno C, Campobasso N, Nardecchia A, et al. Relationship of para- and perirenal fat and epicardial fat with metabolic parameters in overweight and obese subjects. Eat Weight Disord. 2019;24(1):67–72. doi:10.1007/s40519-018-0532-z
   PubMed Web of Science ®Google Scholar
• Chen X, Mao Y, Hu J, et al. Perirenal fat thickness is significantly associated with the risk for development of chronic kidney disease in patients with diabetes. Diabetes. 2021;70(10):2322–2332. doi:10.2337/db20-1031
   PubMed Web of Science ®Google Scholar
• Fang Y, Xu Y, Yang Y, et al. The relationship between perirenal fat thickness and reduced glomerular filtration rate in patients with type 2 diabetes. J Diabetes Res. 2020;2020:6076145. doi:10.1155/2020/6076145
   PubMed Web of Science ®Google Scholar
• Geraci G, Zammuto M, Mattina A, et al. Para-perirenal distribution of body fat is associated with reduced glomerular filtration rate regardless of other indices of adiposity in hypertensive patients. J Clin Hypertens. 2018;20(10):1438–1446. doi:10.1111/jch.13366
   Web of Science ®Google Scholar
• Grima P, Guido M, Zizza A, et al. Sonographically measured perirenal fat thickness: an early predictor of atherosclerosis in HIV-1-infected patients receiving highly active antiretroviral therapy? J Clin Ultrasound. 2010;38(4):190–195. doi:10.1002/jcu.20664
   PubMed Web of Science ®Google Scholar
• Bassols J, Martínez-Calcerrada J, Prats-Puig A, et al. Perirenal fat is related to carotid intima-media thickness in children. Int J Obes. 2018;42(4):641–647. doi:10.1038/ijo.2017.236
   Web of Science ®Google Scholar
• Guo X, Tu M, Chen Y, et al. Perirenal fat thickness: a surrogate marker for metabolic syndrome in Chinese newly diagnosed type 2 diabetes. Front Endocrinol. 2022;13:850334. doi:10.3389/fendo.2022.850334
   PubMed Web of Science ®Google Scholar
• Fukuda K, Seki Y, Ichihi M, et al. Usefulness of ultrasonographic estimation of preperitoneal and subcutaneous fat thickness in the diagnosis of nonalcoholic fatty liver disease in diabetic patients. J Med Ultrason. 2015;42(3):357–363. doi:10.1007/s10396-015-0615-7
   PubMed Web of Science ®Google Scholar
• Wu C, Zhang H, Zhang J, et al. Inflammation and fibrosis in perirenal adipose tissue of patients with aldosterone-producing adenoma. Endocrinology. 2018;159(1):227–237. doi:10.1210/en.2017-00651
   PubMed Web of Science ®Google Scholar
• Sun L, Li F, Han C, et al. Alterations in mitochondrial biogenesis and respiratory activity, inflammation of the senescence-associated secretory phenotype, and lipolysis in the perirenal fat and liver of rats following lifelong exercise and detraining. FASEB J. 2021;35(10):e21890. doi:10.1096/fj.202100868R
   PubMed Web of Science ®Google Scholar
• Vacca M, Allison M, Griffin J, et al. Fatty acid and glucose sensors in hepatic lipid metabolism: implications in NAFLD. Semin Liver Dis. 2015;35(3):250–261. doi:10.1055/s-0035-1562945
   PubMed Web of Science ®Google Scholar
• Caserta F, Tchkonia T, Civelek V, et al. Fat depot origin affects fatty acid handling in cultured rat and human preadipocytes. Am J Physiol Endocrinol Metab. 2001;280(2):E238–47. doi:10.1152/ajpendo.2001.280.2.E238
   PubMed Web of Science ®Google Scholar
• Roerink S, Wagenmakers M, Langenhuijsen J, et al. Increased adipocyte size, macrophage infiltration, and adverse local adipokine profile in perirenal fat in cushing’s syndrome. Obesity. 2017;25(8):1369–1374. doi:10.1002/oby.21887
   PubMed Web of Science ®Google Scholar
• Hoogduijn M, Crop M, Peeters A, et al. Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. Stem Cells Dev. 2007;16(4):597–604. doi:10.1089/scd.2006.0110
   PubMed Web of Science ®Google Scholar
• Francisco V, Sanz M, Real J, et al. Adipokines in non-alcoholic fatty liver disease: are we on the road toward new biomarkers and therapeutic targets? Biology. 2022;11(8):1237. doi:10.3390/biology11081237
   PubMedGoogle Scholar
• Lumeng C, Bodzin J, Saltiel A. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007;117(1):175–184. doi:10.1172/JCI29881
   PubMed Web of Science ®Google Scholar